GlassScriptPhysician profile
Richard Kenneth Bellinger
NPI 1417906488
$8,135.34
in general payments reported to CMS, 2019-2025
55 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $81.46 · 2021: $690 · 2022: $1,092 · 2023: $1,903 · 2024: $1,981 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,681.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,015.32 | 2019-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $790.20 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $740.72 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $639.97 | 2019-2025 | |
| Lilly USA, LLC | $571.96 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $501.04 | 2019-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $486.37 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Bayer Healthcare Pharmaceuticals INC. | $400.47 | 2021-2025 | |
| Astellas Pharma US INC | $296.02 | 2019-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $231.82 | 2020-2025 | Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $173.13 | 2019-2025 | Xifaxan |
| Esperion Therapeutics, INC. | $150.51 | 2021 | |
| Corcept Therapeutics | $145.88 | 2025 | Korlym |
| Merck Sharp & Dohme LLC | $142.63 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Janssen Pharmaceuticals, INC | $126.49 | 2019-2025 | Spravato |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.